X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Biocon Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs BIOCON LTD - Comparison Results

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS BIOCON LTD DR. DATSONS LABS/
BIOCON LTD
 
P/E (TTM) x -10.9 92.4 - View Chart
P/BV x 0.2 7.8 2.1% View Chart
Dividend Yield % 0.0 0.1 -  

Financials

 DR. DATSONS LABS   BIOCON LTD
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
BIOCON LTD
Mar-18
DR. DATSONS LABS/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs1261,188 10.6%   
Low Rs31305 10.1%   
Sales per share (Unadj.) Rs133.068.7 193.5%  
Earnings per share (Unadj.) Rs0.27.6 2.0%  
Cash flow per share (Unadj.) Rs6.614.0 47.3%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.1 0.0%  
Book value per share (Unadj.) Rs128.886.3 149.2%  
Shares outstanding (eoy) m31.66600.00 5.3%   
Bonus/Rights/Conversions FCCBIS-  
Price / Sales ratio x0.610.9 5.4%   
Avg P/E ratio x516.198.9 522.1%  
P/CF ratio (eoy) x11.853.4 22.2%  
Price / Book Value ratio x0.68.6 7.0%  
Dividend payout %013.2 0.0%   
Avg Mkt Cap Rs m2,477447,900 0.6%   
No. of employees `000NA6.1 0.0%   
Total wages/salary Rs m569,311 0.6%   
Avg. sales/employee Rs ThNM6,705.8-  
Avg. wages/employee Rs ThNM1,514.2-  
Avg. net profit/employee Rs ThNM736.9-  
INCOME DATA
Net Sales Rs m4,21141,234 10.2%  
Other income Rs m792,062 3.8%   
Total revenues Rs m4,28943,296 9.9%   
Gross profit Rs m5698,291 6.9%  
Depreciation Rs m2043,851 5.3%   
Interest Rs m430615 70.0%   
Profit before tax Rs m135,887 0.2%   
Minority Interest Rs m0213 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,569 0.4%   
Profit after tax Rs m54,531 0.1%  
Gross profit margin %13.520.1 67.2%  
Effective tax rate %48.026.7 180.2%   
Net profit margin %0.111.0 1.0%  
BALANCE SHEET DATA
Current assets Rs m6,85241,486 16.5%   
Current liabilities Rs m6,71121,413 31.3%   
Net working cap to sales %3.348.7 6.9%  
Current ratio x1.01.9 52.7%  
Inventory Days Days16164 251.5%  
Debtors Days Days31894 338.2%  
Net fixed assets Rs m3,67350,661 7.3%   
Share capital Rs m3173,000 10.6%   
"Free" reserves Rs m3,76148,808 7.7%   
Net worth Rs m4,07851,808 7.9%   
Long term debt Rs m1,67117,898 9.3%   
Total assets Rs m12,63399,897 12.6%  
Interest coverage x1.010.6 9.7%   
Debt to equity ratio x0.40.3 118.6%  
Sales to assets ratio x0.30.4 80.7%   
Return on assets %3.45.2 66.8%  
Return on equity %0.18.7 1.3%  
Return on capital %7.79.6 79.7%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96412,058 8.0%   
Fx outflow Rs m6077,348 8.3%   
Net fx Rs m3574,710 7.6%   
CASH FLOW
From Operations Rs m1,3456,621 20.3%  
From Investments Rs m-2,256-6,840 33.0%  
From Financial Activity Rs m-1,200-2,397 50.1%  
Net Cashflow Rs m-2,111-2,612 80.8%  

Share Holding

Indian Promoters % 4.5 40.4 11.2%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 0.0 8.4 -  
FIIs % 1.4 10.7 12.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 19.9 472.9%  
Shareholders   20,807 109,995 18.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   GSK PHARMA  ASTRAZENECA PHARMA  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

BIOCON LTD Announces Quarterly Results (1QFY19); Net Profit Up 47.2% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, BIOCON LTD has posted a net profit of Rs 1 bn (up 47.2% YoY). Sales on the other hand came in at Rs 11 bn (up 20.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (4QFY18); Net Profit Up 19.8% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 19.8% YoY). Sales on the other hand came in at Rs 12 bn (up 25.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS